Back

Prasugrel or clopidogrel in non-st-elevation acute coronary syndrome with CYP2C19 genetic variants undergoing percutaneous coronary intervention

28 August 2018 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster Session 6 - Pharmacogenetics - New sights on the horizon Antiplatelet Drugs ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Soojin Kim

Busan (Korea (Republic of))

5 More presentations in this session

Presentation thumbnail
Doctor A. Franci (Sao Paulo, BR)
Abstract Slides
Presentation thumbnail
Doctor K. Xu (Shanghai, CN)
Abstract Slides
Presentation thumbnail
Doctor L. Gross (Munich, DE)
Abstract Slides
Presentation thumbnail
Mrs R. Olie (Maastricht, NL)
Abstract
Presentation thumbnail
Doctor J. Li (Busan, KR)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 6 - Pharmacogenetics - New sights on the horizon

The Event

Event poster

ESC Congress 2018

28 August 2018 08:30 CET
You may be interested in
thumbnail
Webinar
Aspirin treatment for mitigating thrombotic risk across the cardiovascular risk continuum
thumbnail
Congress Presentation
Antithrombotic therapy in diabetes
thumbnail
Congress Session
State-of-the-art antithrombotic treatment in acute coronary syndromes: a paradigm shift?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources